Literature DB >> 24637175

Geographic variation in human papillomavirus vaccination uptake among 13-17 year old adolescent girls in the United States.

Mahbubur Rahman1, Christine J McGrath2, Abbey B Berenson2.   

Abstract

Geographic variation in provider-verified human papillomavirus (HPV) vaccine uptake among adolescent girls in the US has not been examined. To investigate this, we analyzed 2011 National Immunization Survey-Teen data. Among 13-17 year old girls (n=11,236), weighted vaccine initiation (48.4%) and completion rates (30.6%) were the lowest in the South when compared to the Northeast (53.4% and 39.9%), Midwest (51.1% and 33.5%) and West (61.6% and 38.7%) (P<.001, both for initiation and completion). Multivariable log-binomial regression analysis indicated that 13-17 year old girls living in the South were less likely to initiate [adjusted prevalence ratio (aPR)=0.86, 95% confidence interval (CI) 0.75-0.97] and complete (aPR=0.83, 95% CI, 0.74-0.93) the HPV vaccine series compared to girls living in the Northeast. Similar differences were observed when the uptake rates in the South were compared to other regions in the US. Intervention programs to increase HPV vaccine uptake and reduce regional disparities are warranted.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Geographic variation; HPV vaccine; Human papillomavirus; NIS-Teen

Mesh:

Substances:

Year:  2014        PMID: 24637175      PMCID: PMC4062082          DOI: 10.1016/j.vaccine.2014.02.097

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Determining accurate vaccination coverage rates for adolescents: the National Immunization Survey-Teen 2006.

Authors:  Nidhi Jain; James A Singleton; Margrethe Montgomery; Benjamin Skalland
Journal:  Public Health Rep       Date:  2009 Sep-Oct       Impact factor: 2.792

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

Review 3.  Prevalence of HPV infection among men: A systematic review of the literature.

Authors:  Eileen F Dunne; Carrie M Nielson; Katherine M Stone; Lauri E Markowitz; Anna R Giuliano
Journal:  J Infect Dis       Date:  2006-09-12       Impact factor: 5.226

4.  Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008.

Authors:  Charlene A Wong; Zahava Berkowitz; Christina G Dorell; Rebecca Anhang Price; Jennifer Lee; Mona Saraiya
Journal:  Cancer       Date:  2011-06-20       Impact factor: 6.860

5.  Geographic disparity, area poverty, and human papillomavirus vaccination.

Authors:  Sandi L Pruitt; Mario Schootman
Journal:  Am J Prev Med       Date:  2010-05       Impact factor: 5.043

6.  Prevalence of HPV infection among females in the United States.

Authors:  Eileen F Dunne; Elizabeth R Unger; Maya Sternberg; Geraldine McQuillan; David C Swan; Sonya S Patel; Lauri E Markowitz
Journal:  JAMA       Date:  2007-02-28       Impact factor: 56.272

Review 7.  Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States--do we need a broader vaccine policy?

Authors:  N Osazuwa-Peters
Journal:  Vaccine       Date:  2013-10-03       Impact factor: 3.641

8.  Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.

Authors:  Meg Watson; Mona Saraiya; Faruque Ahmed; Cheryll J Cardinez; Marsha E Reichman; Hannah K Weir; Thomas B Richards
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

Review 9.  Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality.

Authors:  F Xavier Bosch; Silvia de Sanjosé
Journal:  J Natl Cancer Inst Monogr       Date:  2003

10.  Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.

Authors:  Suzanne M Garland; Marc Steben; Heather L Sings; Margaret James; Shuang Lu; Radha Railkar; Eliav Barr; Richard M Haupt; Elmar A Joura
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

View more
  13 in total

1.  Correlates of Human Papillomavirus Vaccine Completion Among Adolescent Girl Initiators.

Authors:  Mahbubur Rahman; Tabassum H Laz; Christine J McGrath; Abbey B Berenson
Journal:  Clin Pediatr (Phila)       Date:  2015-04-06       Impact factor: 1.168

2.  Sub-Regional Assessment of HPV Vaccination Among Female Adolescents in the Intermountain West and Implications for Intervention Opportunities.

Authors:  Julia Bodson; Qian Ding; Echo L Warner; Amy J Hawkins; Kevin A Henry; Deanna Kepka
Journal:  Matern Child Health J       Date:  2017-07

3.  Regional variations in human papillomavirus prevalence across time in NHANES (2003-2014).

Authors:  Jacqueline M Hirth; Yong-Fang Kuo; Jonathan M Starkey; Richard E Rupp; Tabassum H Laz; Mahbubur Rahman; Abbey B Berenson
Journal:  Vaccine       Date:  2019-06-07       Impact factor: 3.641

4.  Human Papillomavirus Vaccine Uptake, Knowledge, and Acceptance for Youth: A Systematic Review of Appalachia.

Authors:  Chelsea Ryan; Kathryn L Duvall; Emily C Weyant; Kiana R Johnson; David Wood
Journal:  J Community Health       Date:  2018-06

5.  Provider recommendation mediates the relationship between parental human papillomavirus (HPV) vaccine awareness and HPV vaccine initiation and completion among 13- to 17-year-old U.S. adolescent children.

Authors:  Mahbubur Rahman; Tabassum H Laz; Christine J McGrath; Abbey B Berenson
Journal:  Clin Pediatr (Phila)       Date:  2014-09-19       Impact factor: 1.168

6.  Geographic Factors and Human Papillomavirus (HPV) Vaccination Initiation among Adolescent Girls in the United States.

Authors:  Kevin A Henry; Antoinette M Stroup; Echo L Warner; Deanna Kepka
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-01-14       Impact factor: 4.254

7.  Regional variation in mammography use among insured women 40-49 years old: impact of a USPSTF guideline change.

Authors:  Jacqueline M Hirth; Yong-Fang Kuo; Yu-Li Lin; Abbey B Berenson
Journal:  J Health Sci (El Monte)       Date:  2015-04-30

8.  Geospatial patterns of human papillomavirus vaccine uptake in Minnesota.

Authors:  Erik J Nelson; John Hughes; J Michael Oakes; James S Pankow; Shalini L Kulasingam
Journal:  BMJ Open       Date:  2015-08-27       Impact factor: 2.692

9.  Human papillomavirus vaccine uptake among individuals with systemic inflammatory diseases.

Authors:  Candace H Feldman; Linda T Hiraki; Huichuan Lii; John D Seeger; Seoyoung C Kim
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

10.  Area-Level Variation and Human Papillomavirus Vaccination among Adolescents and Young Adults in the United States: A Systematic Review.

Authors:  Elizabeth K Do; Brianna Rossi; Carrie A Miller; Albert J Ksinan; David C Wheeler; Askar Chukmaitov; John W Cyrus; Bernard F Fuemmeler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10-02       Impact factor: 4.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.